Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen

Vaccine
Bram SlütterWim Jiskoot

Abstract

Nasal vaccination is a promising, needle-free alternative to classical vaccination. Nanoparticulate delivery systems have been reported to overcome the poor immunogenicity of nasally administered soluble antigens, but the characteristics of the ideal particle are unknown. This study correlates differences in physicochemical characteristics of nanoparticles to their adjuvant effect, using ovalbumin (OVA)-loaded poly(lactic-co-glycolic acid) nanoparticles (PLGA NP), N-trimethyl chitosan (TMC) based NP (TMC NP) and TMC-coated PLGA NP (PLGA/TMC NP). PLGA NP and PLGA/TMC NP were prepared by emulsification/solvent extraction and TMC NP by ionic complexation. The NP were characterized physicochemically. Their toxicity and interaction with and stimulation of monocyte derived dendritic cells (DC) were tested in vitro. Furthermore, the residence time and the immunogenicity (serum IgG titers and secretory IgA levels in nasal washes) of the nasally applied OVA formulations were assessed in Balb/c mice. All NP were similar in size, whereas only PLGA NP carried a negative zeta potential. The NP were non-toxic to isolated nasal epithelium. Only TMC NP increased the nasal residence time of OVA compared to OVA administered in PBS and induced DC...Continue Reading

References

Jul 1, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M E Baca-EstradaM Snider
Sep 16, 1999·Journal of Biomaterials Science. Polymer Edition·D LemoineV Préat
Oct 24, 2001·Journal of Substance Abuse Treatment·G H De Weert-Van OeneG J Schrijvers
Nov 25, 2004·Advanced Drug Delivery Reviews·Ying Waeckerle-Men, Marcus Groettrup
Feb 24, 2005·International Journal of Pharmaceutics·A VilaM J Alonso
Mar 18, 2005·Annual Review of Immunology·E Sergio Trombetta, Ira Mellman
Apr 16, 2005·The Journal of Pharmacy and Pharmacology·Svetlana DimovaPatrick Augustijns
May 14, 2005·Expert Review of Vaccines·Magnus Köping-HöggårdMaría José Alonso
May 27, 2005·Vaccine·Robert C ReadRoy Jennings
Nov 5, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Asteria Luzardo-AlvarezBruno Gander
Dec 29, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maryam AmidiWim Jiskoot
Sep 12, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Giuseppina SandriCarla Caramella
Dec 26, 2006·Medical Molecular Morphology·Yoshinori FujimuraKen Haruma
Jan 4, 2008·Journal of Drug Targeting·Bram SlütterWim Jiskoot
Jan 10, 2008·International Journal of Pharmaceutics·Kapil KhatriSuresh P Vyas
Jul 29, 2008·Journal of Pharmaceutical Sciences·Sameer SharmaYan Chen
Apr 22, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Owen I Corrigan, Xue Li
May 5, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·A H GhassemiW E Hennink
May 19, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bram SlütterVéronique Préat
Aug 29, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Niels HagenaarsWim Jiskoot
Nov 21, 2009·Advanced Drug Delivery Reviews·Maryam AmidiWim E Hennink
Jan 16, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bram SlütterWim Jiskoot
Jan 16, 2010·The AAPS Journal·Dilip PawarSuresh P Vyas
Jan 27, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Niels HagenaarsWim Jiskoot

❮ Previous
Next ❯

Citations

Jul 27, 2012·Therapeutic Delivery·David J Brayden, Randall J Mrsny
Apr 25, 2013·Cancer Immunology, Immunotherapy : CII·Rodney A RosaliaJaap Oostendorp
Jan 15, 2013·Drug Delivery and Translational Research·Mehfuz ZamanIstvan Toth
Nov 4, 2015·Vaccines·Liam PowlesMagdalena Plebanski
Feb 16, 2016·Carbohydrate Polymers·Jatesuda JirawutthiwongchaiSuwabun Chirachanchai
May 9, 2015·Expert Opinion on Drug Delivery·Yimei JiaAbdelwahab Omri
Jun 26, 2014·Expert Opinion on Drug Delivery·Peggy RieseCarlos A Guzmán
Jun 20, 2012·Expert Opinion on Drug Delivery·Inderjit Jabbal-GillAlan Smith
Oct 28, 2015·Journal of Pharmaceutical Sciences·Iman AlfagihImran Y Saleem
Jan 18, 2016·Journal of Colloid and Interface Science·Jeong-Jun LeeHyun-Jong Cho
Dec 4, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A L SilvaW Jiskoot
Oct 11, 2012·Biomaterials·Christophe Y Dombu, Didier Betbeder
Jul 10, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Sílvia A FerreiraManuel Vilanova
Jan 12, 2016·Human Vaccines & Immunotherapeutics·A L SilvaW Jiskoot
Apr 7, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marcos Garcia-Fuentes, Maria J Alonso
Feb 15, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hoang HirschbergJean-Pierre Amorij
Feb 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Feb 4, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lisbeth Illum
Oct 20, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Suzanne M BalWim Jiskoot
Feb 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bram SlütterJoke A Bouwstra
Mar 5, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·René RietscherClaus-Michael Lehr
Oct 5, 2014·Advanced Drug Delivery Reviews·Zohreh Amoozgar, Michael S Goldberg
Jun 7, 2015·Biotechnology Advances·Ana Sara CordeiroMaría de la Fuente
Jul 6, 2013·Materials Science & Engineering. C, Materials for Biological Applications·Kedong SongTianqing Liu
Jun 6, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Javier ParraAntonio Abad-Fuentes
Apr 1, 2015·Pharmaceutical Research·Stefan SchillerClaus-Michael Lehr
Jul 17, 2012·Expert Opinion on Therapeutic Targets·Chantal KeijzerFemke Broere
Apr 4, 2015·Human Vaccines & Immunotherapeutics·Chi-Ying LinMing-Kung Yeh
Aug 11, 2015·International Journal of Pharmaceutical Investigation·Deepak SharmaShweta Dang
Apr 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuchen FanJames J Moon
Jan 18, 2015·International Journal of Pharmaceutics·Regina ScherließSarah Hook
Oct 1, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sara VicenteMaría J Alonso
Oct 30, 2015·Human Vaccines & Immunotherapeutics·Mojgan Allahyari, Elham Mohit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.